This month shares of life sciences company Bionano have seen gains of over 300% and the company this week announced some pretty big news. On Monday Bionano disclosed that its genome mapping platform Saphyr has been accredited in the US by the College of American Pathologists. The platform will be used by Bionano’s customer Praxis … Continue reading “Analyst Says Bionano’s Genome Mapping Platform Could Be a Game Changer”
